XML 34 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments and Risk Management
12 Months Ended
Dec. 31, 2017
Investments, All Other Investments [Abstract]  
Financial Instruments and Risk Management

NOTE 12 - FINANCIAL INSTRUMENTS AND RISK MANAGEMENT:

 

  a. General

The Company operates internationally, which gives rise to exposure to market risks, mainly from changes in foreign exchange rates. The Company uses financial instruments and derivatives to hedge its balance sheet exposures as well as certain future cash flows in connection with revenues, payroll and related expenses and anticipated probable transactions which are expected to be denominated in non-Dollar currencies.

The Company is exposed to losses in the event of non-performance by counterparties to financial instruments; however, as the counterparties are major Israeli, European and U.S. banks, the Company does not expect any counterparties to fail to meet their obligations. The Company does not require or place collateral with respect to these financial instruments. The Company does not hold or issue derivatives for trading purposes.

 

  b. Derivative instruments

As noted in Note 1s, the Company enters into various types of foreign exchange derivatives in managing its foreign exchange risks. The notional amounts of these derivatives as of December 31, 2017 were as follows:

 

     $ in millions  

Forward exchange for conversion of:

  

Euros into Dollars

     14.4  
  

 

 

 

Japanese Yen into Dollars

     56.8  
  

 

 

 

Dollars into NIS

     30.4  
  

 

 

 

Korean Won into Dollars

     23.1  
  

 

 

 

Taiwan Dollars into Dollars

     21.2  
  

 

 

 

Dollars into British Pounds

     10.7  
  

 

 

 

The terms of most of these currency derivatives are less than one year.

The following table summarizes activity in accumulated other comprehensive (income) loss related to derivatives classified as foreign currency cash flow hedges held by the Company during the reported years:

 

     Year ended December 31  
     2017      2016      2015  
     $ in thousands  

Balance at beginning of year

     (9,087      (1,477      (1,928

Unrealized gain (losses) from derivatives

     4,113      (30,066      (4,155

Reclassifications into earnings from other comprehensive loss (income):

        

included in revenues

     (48      1,203      (248

included in financial expenses - net

     4,749      14,951   

included in various statements of operations and financial items

     1,529      5,542      4,969

Tax effect

     (923      760      (115
  

 

 

    

 

 

    

 

 

 

Balance at end of year

     333      (9,087      (1,477
  

 

 

    

 

 

    

 

 

 

 

  c. Fair value of financial instruments

The fair value of financial instruments included in working capital is usually close or identical to their carrying amounts. The fair value of non-current other receivables and long-term liabilities, including long-term loans, also approximates the carrying amounts, since they bear interest at rates close to prevailing market rates.

 

The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2017 and 2016, consistent with the fair value hierarchy provisions of the applicable accounting rules:

 

     Level 1      Level 2      Level 3      Total  
     $ in thousands  

December 31, 2017:

           

Assets:

           

Marketable securities

     7,888              7,888  
  

 

 

          

 

 

 

Derivative assets designated as hedging instruments

        333           333  
     

 

 

       

 

 

 

Derivative assets not designated as hedging instruments

        306           306  
     

 

 

       

 

 

 

Liabilities:

           

Derivative liabilities not designated as hedging instruments

        1,214           1,214  
     

 

 

       

 

 

 

December 31, 2016:

           

Assets:

           

Marketable securities

     7,012              7,012  
  

 

 

          

 

 

 

Derivative assets designated as hedging instruments

        402           402  
     

 

 

       

 

 

 

Derivative assets not designated as hedging instruments

        4,336           4,336  
     

 

 

       

 

 

 

Liabilities:

           

Derivative liabilities designated as hedging instruments

        9,489           9,489  
     

 

 

       

 

 

 

Derivative liabilities not designated as hedging instruments

        130           130  
     

 

 

       

 

 

 

Contingent consideration in connection with the AMST assets acquisition

           1,471        1,471  
        

 

 

    

 

 

 

Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2 - Valuations based on quoted prices in markets that are not active but for which all significant inputs are observable, either directly or indirectly. Derivatives, as described in b. above, are of value primarily based on observable inputs including interest rate curves and both forward and spot prices for currencies and the Company is therefore able to perform independent verification in order to validate quotations obtained.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. These estimated fair values are subject to uncertainties that are difficult to predict.